Susquehanna International Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Hold
0
7283
2024
Q4
Hold
0
6994
2024
Q3
Sell
-30,005
Closed -$155K 6735
2024
Q2
$155K Buy
+30,005
New +$155K ﹤0.01% 4903
2024
Q1
Hold
0
6797
2023
Q4
Hold
0
6766
2023
Q3
Hold
0
6531
2023
Q2
Sell
-19,633
Closed -$52.4K 6622
2023
Q1
$52.4K Sell
19,633
-23,614
-55% -$63K ﹤0.01% 5433
2022
Q4
$155K Buy
43,247
+33,042
+324% +$119K ﹤0.01% 4673
2022
Q3
$66K Sell
10,205
-12,666
-55% -$81.9K ﹤0.01% 5421
2022
Q2
$220K Buy
22,871
+20,238
+769% +$195K ﹤0.01% 4441
2022
Q1
$31K Sell
2,633
-13,969
-84% -$164K ﹤0.01% 5408
2021
Q4
$541K Sell
16,602
-4,723
-22% -$154K ﹤0.01% 3684
2021
Q3
$953K Buy
21,325
+6,674
+46% +$298K ﹤0.01% 2824
2021
Q2
$798K Buy
14,651
+5,607
+62% +$305K ﹤0.01% 3299
2021
Q1
$676K Sell
9,044
-764
-8% -$57.1K ﹤0.01% 3492
2020
Q4
$1.07M Buy
9,808
+2,684
+38% +$291K ﹤0.01% 2513
2020
Q3
$629K Buy
7,124
+4,850
+213% +$428K ﹤0.01% 2779
2020
Q2
$242K Sell
2,274
-1,099
-33% -$117K ﹤0.01% 3554
2020
Q1
$200K Buy
3,373
+1,560
+86% +$92.5K ﹤0.01% 3793
2019
Q4
$125K Buy
1,813
+235
+15% +$16.2K ﹤0.01% 3636
2019
Q3
$164K Buy
1,578
+140
+10% +$14.6K ﹤0.01% 3932
2019
Q2
$133K Buy
+1,438
New +$133K ﹤0.01% 4070
2019
Q1
Sell
-2,643
Closed -$147K 4738
2018
Q4
$147K Buy
+2,643
New +$147K ﹤0.01% 3072
2018
Q3
Hold
0
4888
2018
Q2
Hold
0
4883
2018
Q1
Hold
0
4694
2017
Q4
Hold
0
4652